These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 7033385

  • 21. Characterization of the rat neutrophil formyl peptide chemotaxis receptor.
    Marasco WA, Fantone JC, Freer RJ, Ward PA.
    Am J Pathol; 1983 Jun; 111(3):273-81. PubMed ID: 6305198
    [Abstract] [Full Text] [Related]

  • 22. Formyl peptide leukocyte chemoattractant uptake and release by cultured human umbilical vein endothelial cells.
    Rotrosen D, Malech HL, Gallin JI.
    J Immunol; 1987 Nov 01; 139(9):3034-40. PubMed ID: 3668252
    [Abstract] [Full Text] [Related]

  • 23. Chemotactic deactivation of human neutrophils: relationship to loss of cytotaxin receptor function and temporal nature of the phenomenon.
    Nelson RD, Fiegel VD, Herron MJ, Simmons RL.
    J Reticuloendothel Soc; 1980 Sep 01; 28(3):285-94. PubMed ID: 7411541
    [No Abstract] [Full Text] [Related]

  • 24. Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist.
    Dahinden C, Fehr J.
    J Clin Invest; 1980 Nov 01; 66(5):884-91. PubMed ID: 7430350
    [Abstract] [Full Text] [Related]

  • 25. Chemotaxis, spreanding nd oxidative metabolism of neutrophils: influence of albumin in vitro.
    Valerius NH.
    Acta Pathol Microbiol Immunol Scand C; 1983 Feb 01; 91(1):43-9. PubMed ID: 6306991
    [Abstract] [Full Text] [Related]

  • 26. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli.
    Marasco WA, Phan SH, Krutzsch H, Showell HJ, Feltner DE, Nairn R, Becker EL, Ward PA.
    J Biol Chem; 1984 May 10; 259(9):5430-9. PubMed ID: 6371005
    [Abstract] [Full Text] [Related]

  • 27. Modulation of granulocyte response to the chemoattractant F-Met-Leu-Phe.
    Dahlgren C, Stendahl O.
    Adv Exp Med Biol; 1982 May 10; 155():107-12. PubMed ID: 6297266
    [No Abstract] [Full Text] [Related]

  • 28. Demonstration of a chemotactic factor receptor on macrophages.
    Snyderman R, Fudman EJ.
    J Immunol; 1980 Jun 10; 124(6):2754-7. PubMed ID: 7373048
    [Abstract] [Full Text] [Related]

  • 29. A monoclonal antibody-inhibiting FMLP-induced chemotaxis of human neutrophils.
    Cotter TG, Keeling PJ, Henson PM.
    J Immunol; 1981 Dec 10; 127(6):2241-5. PubMed ID: 7053244
    [Abstract] [Full Text] [Related]

  • 30. Conformationally constrained formyl methionyl tripeptides: structure-function study of analogs containing alpha,beta-dehydrophenylalanine and dehydroleucine.
    Bharadwaj A, Singh M, Bhandary K, Becker EL, Chauhan VS.
    Pept Res; 1993 Dec 10; 6(6):298-307. PubMed ID: 8292847
    [Abstract] [Full Text] [Related]

  • 31. Formyl peptide chemoattractants. Synthesis and chemotactic activity.
    Falcomer C, Vertuani G, Boggian M, Scatturin A, Spisani S, Cavalletti T, Traniello S.
    Farmaco Sci; 1987 Nov 10; 42(11):815-22. PubMed ID: 3443176
    [Abstract] [Full Text] [Related]

  • 32. Effect of arachidonic acid and the chemotactic factor F-Met-Leu-Phe on cation transport in rabbit neutrophils.
    Sha'afi RI, Naccache PH, Alobaidi T, Molski TF, Volpi M.
    J Cell Physiol; 1981 Feb 10; 106(2):215-23. PubMed ID: 7217212
    [Abstract] [Full Text] [Related]

  • 33. Histamine modulation of human neutrophil oxidative metabolism, locomotion, degranulation, and membrane potential changes.
    Seligmann BE, Fletcher MP, Gallin JI.
    J Immunol; 1983 Apr 10; 130(4):1902-9. PubMed ID: 6131922
    [Abstract] [Full Text] [Related]

  • 34. Determination of a specific receptor for formyl-methionyl-leucyl-phenylalanine on th pulmonary alveolar macrophage and its relationship to chemotaxis and superoxide production.
    Spilberg I, Mehta J, Daughaday C, Simchowitz L.
    J Lab Clin Med; 1981 May 10; 97(5):602-9. PubMed ID: 6260878
    [Abstract] [Full Text] [Related]

  • 35. A new procedure to analyse the role of adhesion to solid substrata and of motility in chemokinesis of neutrophil granulocytes.
    Keller HU, Cottier H.
    Prog Clin Biol Res; 1982 May 10; 85 Pt B():415-23. PubMed ID: 6181523
    [Abstract] [Full Text] [Related]

  • 36. Activation of the rabbit polymorphonuclear leukocyte membrane "Na+, K+"-ATPase by chemotactic factor.
    Becker EL, Talley V, Showell HJ, Naccache PH, Sha'afi RI.
    J Cell Biol; 1978 May 10; 77(2):329-33. PubMed ID: 148465
    [Abstract] [Full Text] [Related]

  • 37. Chemotactic factors trigger their own oxidative inactivation by human neutrophils.
    Clark RA.
    J Immunol; 1982 Dec 10; 129(6):2725-8. PubMed ID: 7142703
    [Abstract] [Full Text] [Related]

  • 38. [An analog of formyl-met-leu-phe effects the movement of human leukocytes].
    Cavalletti T, Spisani S, Gavioli R, Marangoni C, Scatturin A, Vertuani G, Traniello S.
    Boll Soc Ital Biol Sper; 1984 Jun 30; 60(6):1103-9. PubMed ID: 6548144
    [Abstract] [Full Text] [Related]

  • 39. Structure-activity relationship of for-L-Met L-Leu-L-Phe-OMe analogues in human neutrophils.
    Cavicchioni G, Fraulini A, Falzarano S, Spisani S.
    Bioorg Chem; 2006 Oct 30; 34(5):298-318. PubMed ID: 16919307
    [Abstract] [Full Text] [Related]

  • 40. Phloretin is a potent inhibitor of rabbit neutrophil activation by chemotactic factors.
    Shefcyk J, Molski TF, Volpi M, Naccache PH, Sha'afi RI.
    Biochim Biophys Acta; 1983 Feb 09; 728(1):97-102. PubMed ID: 6830775
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.